Background Patients with severe aortic stenosis (AS) are at high risk of mortality, regardless of symptom status. Despite ...

Step counts and heart rates are no longer enough. Passive tracking is giving way to intelligent and active protection.

Dana Friesen, CEO of Summit Sciences, brings over 15 years of experience in financial analysis and ROI optimization within the medical device sector. The firm has delivered billions in lifetime ...

Since it went on the market, the newer device has been the subject of several reports of hemolysis. This would seem ...

PMI’s FDA-approved SynCardia STAH is promising, but adoption and revenues lag; cash burn and dilution weigh. Read the full ...

Boston Scientific has long used mergers and acquisitions to fuel growth. This deal appears to be its largest since its ...

With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.

Boston Scientific agreed to buy medtech firm Penumbra in a $14.5  billion deal on Thursday, its second‑largest takeover ever, ...

While AliveCore faced two wins, the dispute did not end there. In March 2025, Apple triumphed in a major patent dispute with ...

Onassis Hospital has taken a major step forward in heart transplantation with the acquisition of a state-of-the-art heart ...

Elixir Medical's DynamX Bioadaptor restores natural artery function, reducing the risk of future cardiac events.

The clinic will be able to accommodate 1,500 patients over a long period and 50 patients with a left ventricular assist ...